Carolina Clinical Research conducts clinical trials in several areas. Working closely with drug manufactures and study sponsors, we ensure the safe, comfortable, and effective administration of clinical trial medications.
While we may have trials covering several clinical areas, our principal investigators and clinical staff specialize in Pulmonary Disorders (including COPD and Asthma) and Infectious Diseases (including COVID-19)
ACTIV-2: A Study for Outpatients with COVID-19. Learn more here
RPL554-CO-302: A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients with COPD
EFC16725: Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-1). Learn more here